GUARD.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$263M	+1152.4%	$-1.04	$-1.04–$-1.04	—	1
2027	$15M	-94.3%	$-1.09	$-1.09–$-1.09	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 2 of the last 2 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-05-11	$-8.63	$-0.31	+96.4%
2026-02-20	$-9.00	$-0.81	+91.0%

DCF fair valuemodel estimate

Intrinsic value

$2.81

Price

$1.47

Implied upside

+92%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
GUARD.STGuard Therapeutics International AB (publ)	$1.47	+0.00%	$30M	—
2CUREX.ST2cureX AB (publ)	$0.42	-12.13%	$11M	—
APTA.STAptahem AB (publ)	$0.38	-14.35%	$10M	—
EPIS-B.STEpisurf Medical AB	$0.07	-2.53%	$56M	—
FLUI.STFluicell AB (publ)	$32.80

Guard Therapeutics International AB (publ)

Guard Therapeutics International AB (publ) is a Swedish pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the diagnosis and management of acute kidney injuries. A key offering is ROSGard, a biological drug candidate designed to prevent kidney impairment through the protection, purification, and restoration of affected cells and tissues. Founded in 2008, the company operated as A1M Pharma AB (publ) until its renaming to Guard Therapeutics International AB (publ) in October 2019. Its headquarters are located in Stockholm, Sweden.

guardtherapeutics.com

Employees: 12
IPO / List date: Apr 3, 2013
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds GUARD.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in GUARD.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded GUARD.ST yet.